Takeda Antitrust Trial Over Actos Generics Set For July

A New York federal court refused a bid from Takeda Pharmaceuticals Co. to escape a long-running case accusing it of unlawfully delaying generic versions of its diabetes treatment Actos and scheduled...

Already a subscriber? Click here to view full article